Launch of the Journal of 3D Printing in Medicine announced
Future Science Group (FSG) is excited to announce the launch of the Journal of 3D Printing in Medicine, a new peer-reviewed online and print publication dedicated to addressing all aspects of medical 3D printing.
Future Science Group (FSG) is excited to announce the launch of the Journal of 3D Printing in Medicine, a new peer-reviewed online and print publication dedicated to addressing all aspects of medical 3D printing. The journal is the latest addition to the internationally recognized Future Medicine portfolio and is supported by a multidisciplinary, international editorial board comprising leading researchers and opinion leaders from academia and industry.
The Journal of 3D Printing in Medicine encompasses all aspects of bioprinting and 3D printing of relevance to medicine and provides a forum for research, review and commentary in a fast-moving, inter-disciplinary research area. Journal of 3D Printing in Medicine presents key data and opinions as they emerge. The coverage spans many fields, including biomedical engineering, medical devices, surgical guides, tissue engineering and biomaterials, as well as covering regulatory and safety issues, patents and health economics.
Editorial Director Laura Dormer commented: “We are delighted to launch this new journal in such an exciting emerging field. 3D printing is set to have a huge impact on the future of healthcare, and I look forward to reading about these exciting developments in the journal.”
This issue is opened with a foreword from the Editor-in-Chief Dietmar Hutmacher and contains a variety of articles, including Editorials by Michael Gelinsky and David Williams discussing where the direction of future focus in 3D printing research may be heading. In a Short Communication, Gelinsky also explores extrusion-based 3D printing. Daniel Thomas, Zita Jessop and Iain Whitaker’s Methodology article describe the production of 3D bioprinted ear structures for the use of reconstructive surgery. The characteristics and production ease of 3D printed, drug-loaded implants to treat alcohol misuse is presented in Michael Davies’s research article. There are also two review articles with Margaret Prendergast looking at the current and future potential of biofabrication bioinks; and coverage of the role of IT in 3D bioprinting from Jorge Vicente Lopes da Silva. Finally there is also an enlightening interview with Pankaj Chandak where he discusses the role of 3D printing of model kidneys for use in surgical planning.
The full contents list for the first issue as well as articles published ahead of print can be viewed at: http://www.futuremedicine.com/loi/3dp
